Your browser doesn't support javascript.
loading
Obesity-associated changes in molecular biology of primary breast cancer.
Nguyen, Ha-Linh; Geukens, Tatjana; Maetens, Marion; Aparicio, Samuel; Bassez, Ayse; Borg, Ake; Brock, Jane; Broeks, Annegien; Caldas, Carlos; Cardoso, Fatima; De Schepper, Maxim; Delorenzi, Mauro; Drukker, Caroline A; Glas, Annuska M; Green, Andrew R; Isnaldi, Edoardo; Eyfjörð, Jórunn; Khout, Hazem; Knappskog, Stian; Krishnamurthy, Savitri; Lakhani, Sunil R; Langerod, Anita; Martens, John W M; McCart Reed, Amy E; Murphy, Leigh; Naulaerts, Stefan; Nik-Zainal, Serena; Nevelsteen, Ines; Neven, Patrick; Piccart, Martine; Poncet, Coralie; Punie, Kevin; Purdie, Colin; Rakha, Emad A; Richardson, Andrea; Rutgers, Emiel; Vincent-Salomon, Anne; Simpson, Peter T; Schmidt, Marjanka K; Sotiriou, Christos; Span, Paul N; Tan, Kiat Tee Benita; Thompson, Alastair; Tommasi, Stefania; Van Baelen, Karen; Van de Vijver, Marc; Van Laere, Steven; Van't Veer, Laura; Viale, Giuseppe; Viari, Alain.
Afiliación
  • Nguyen HL; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Aparicio S; Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
  • Bassez A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Borg A; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Brock J; VIB Center for Cancer Biology, Leuven, Belgium.
  • Broeks A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.
  • Caldas C; Lund University Cancer Center Lund, Lund, Sweden.
  • Cardoso F; CREATE Health Strategic Centre for Translational Cancer Research, Lund University, Lund, Sweden.
  • De Schepper M; Department of Clinical Sciences, SCIBLU Genomics, Lund University, Lund, Sweden.
  • Delorenzi M; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Drukker CA; Departments of Core Facility, Molecular Pathology and Biobanking, Antoni van Leeuwenhoek, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Glas AM; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Green AR; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.
  • Isnaldi E; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Eyfjörð J; Department of Oncology, University of Lausanne, Epalinges, Switzerland.
  • Khout H; SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Lausanne, Switzerland.
  • Knappskog S; Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Krishnamurthy S; Agendia, Amsterdam, the Netherlands.
  • Lakhani SR; Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Langerod A; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Martens JWM; BioMedical Center, School of Health Sciences, Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
  • McCart Reed AE; Department of Breast Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Murphy L; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.
  • Naulaerts S; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Nik-Zainal S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nevelsteen I; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Neven P; Pathology Queensland, The Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
  • Piccart M; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen, Oslo, Norway.
  • Poncet C; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Punie K; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Purdie C; University of Manitoba and Cancer Care Manitoba Research Institute, Winnipeg, MB, Canada.
  • Rakha EA; Laboratory of Cell Stress & Immunity, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Richardson A; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Rutgers E; MRC Cancer Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Vincent-Salomon A; Department of Surgical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Simpson PT; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Schmidt MK; Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium.
  • Sotiriou C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Span PN; Department of General Medical Oncology and Multidisciplinary Breast Unit, Leuven Cancer Institute and University Hospitals Leuven, Leuven, Belgium.
  • Tan KTB; Department of Pathology, University of Dundee, NHS Tayside, Dundee, UK.
  • Thompson A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
  • Tommasi S; Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, UK.
  • Van Baelen K; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Van de Vijver M; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Van Laere S; Diagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.
  • Van't Veer L; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Viale G; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Viari A; Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
Nat Commun ; 14(1): 4418, 2023 07 21.
Article en En | MEDLINE | ID: mdl-37479706
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article